Key Takeaways
Citizens initiates coverage on Stereotaxis (STXS) with a “Market Outperform” rating. Price target set at $4.00 USD by analyst Daniel Staud
Citizens initiates coverage on Stereotaxis (STXS) with a “Market Outperform” rating. Price target set at $4.00 USD by analyst Daniel Staud